News

1 to 9 of 95916 results

Pfizer and Merck to explore potential of Xalkori/pembrolizumab combo

Pfizer and Merck to explore potential of Xalkori/pembrolizumab combo

26-08-2014

US pharma giants Pfizer and Merck & Co have inked an agreement to explore the therapeutic potential of…

Merck & CoOncologypembrolizumabPfizerPharmaceuticalResearchXalkori

Health Canada OKs Biogen Idec’s hemophilia A therapy Eloctate

Health Canada OKs Biogen Idec’s hemophilia A therapy Eloctate

26-08-2014

Canadian regulator Health Canada has approved US Biotech major Biogen Idec’s Eloctate (antihemophilic…

Biogen IdecBiotechnologyCanadaEloctateHematologyRegulationSwedish Orphan Biovitrum

Recipharm inks deal with Isofol Medical on Modufolin

Recipharm inks deal with Isofol Medical on Modufolin

26-08-2014

Swedish contract development and manufacturing group Recipharm and Isofol Medical AB, a Gothenburg-based…

FinancialIsofol MedicalModufolinOncologyPharmaceuticalProductionRecipharmResearch

Concert Pharmaceuticals achieves $2 million milestone for its AVP-786

Concert Pharmaceuticals achieves $2 million milestone for its AVP-786

26-08-2014

USA-based Concert Pharmaceuticals has achieved a $2 million milestone under its development and license…

Avanir PharmaceuticalsAVP-786Concert PharmaceuticalsMajor depressive disorderMedicineNeurochemistryNeurologicalPharmaceuticalPharmacologyResearchTreatment of major depressive disorderUSA

Lysosomal storage disorders are a particularly lucrative corner of ultra-orphan market

Lysosomal storage disorders are a particularly lucrative corner of ultra-orphan market

26-08-2014

A new report by Thomson Reuters has highlighted the economic power of ultra-orphan diseases, the informal…

GenzymeGenzymeLysosomal storage disordersMedicinePharmaceuticalRare diseasesRare inherited metabolic disordersResearchThomson ReutersTreatment for lysosomal storage disordersUltra-orphan diseases

Advaxis and Merck & Co collaborate on prostate cancer

Advaxis and Merck & Co collaborate on prostate cancer

26-08-2014

US cancer immunotherapies firm Advaxis has entered into a clinical trial collaboration agreement with…

AdvaxisADXS-PSABiotechnologyLicensingMerck & CoOncologypembrolizumabResearch

Alkermes files NDA for aripiprazole lauroxil in schizophrenia

Alkermes files NDA for aripiprazole lauroxil in schizophrenia

26-08-2014

Ireland-headquartered biotech firm Alkermes has submitted a New Drug Application to the US Food and Drug…

AbilifyAlkermesaripiprazole lauroxilBiotechnologyNeurologicalRegulationUSA

Strong growth forecast for glioblastoma multiforme therapeutics in Asia-Pacific

Strong growth forecast for glioblastoma multiforme therapeutics in Asia-Pacific

26-08-2014

The glioblastoma multiforme therapeutics market in the four Asia-Pacific markets of Australia, China,…

Asia-PacificAustraliaAvastinCelldex TherapeuticsChinaCotaraIndiaJapanMarkets & MarketingOncologyPeregrine PharmaceuticalsPharmaceuticalrindopepimutRoche

1 to 9 of 95916 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top